Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma productsBusiness Overview: Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets
Remedium Lifecare has reported robust financial results for the quarter ended June 30, 2025. The company achieved a Profit After Tax (PAT) of ₹4.65 Cr, a significant turnaround from a ₹2.05 Cr loss in the previous quarter. Notably, this Q1 PAT already surpasses and doubles the entire FY25 profit of...
Remedium Lifecare is charting long-term growth by expanding its global footprint. The company established REMLIFE GLOBAL PTE. LTD. in Singapore to streamline international operations and engage global investors. This strategic move aligns with securing a multi-year USD 21 Million export contract with a leading pharmaceutical distributor, signifying a shift towards...
Remedium Lifecare's Registrar and Share Transfer Agent reported that for the most recent quarter, there were no requests to convert the company's physical equity shares into electronic (demat) form. This update confirms routine compliance and indicates no activity in the dematerialization of shares during the period, providing transparency on shareholder...
Remedium Lifecare Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company has completed dispatch of the postal ballot notice to shareholders for special and ordinary resolutions, with remote e-voting enabled. Voting rights are based on shareholding as of the cut-off date....
Remedium Lifecare Ltd. has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income of ₹8222.85 lakh for the quarter and ₹26498.20 lakh for the year. It recorded a net loss of ₹264.34 lakh for the quarter and ₹204.60 lakh for...
